EnteroMedics Reports Fourth Quarter 2012 Financial Results

[at noodls] – ST. PAUL, MN — (Marketwire) — 02/13/13 — EnteroMedics Inc. (NASDAQ: ETRM), the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal … more

View todays social media effects on ETRM

View the latest stocks trending across Twitter. Click to view dashboard

See who EnteroMedics is hiring next, click here to view